For instance, TGF-β-induced transgelins could promote bladder cancer metastasis (51), and the TGF-β-related miR-1305/TGF-β2/smad3 pathway was shown to help circRIP2 accelerate bladder cancer development (52). Here, SMAD3 is linked to urinary bladder carcinoma.